STERIS (STE) continues to gain from a strong rebound in procedure volumes in the United States within the Healthcare business. New acquisitions and partnerships should strengthen its product offerings. Yet macroeconomic challenges continue to dampen growth. The stock carries a Zacks Rank #3 (Hold) currently.Factors Driving STERIS' GrowthSTERIS’ Healthcare segment is gaining from the successful market adoption of its comprehensive offerings, including infection prevention consumables and capital equipment. F ...